Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥ 65 years) with type 2 diabetes
about
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials.MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging.Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Saxagliptin: A Review in Type 2 Diabetes.Saxagliptin for the treatment of diabetes - a focus on safety.Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study.
P2860
Q33732627-15885DE5-7FB3-43E7-8981-42223475BCEDQ36184087-60F8510E-47A9-45FB-B337-763691E51450Q38335751-0CDBF27F-D9F7-4EEA-9D39-3A63AF82F9FCQ38592351-B08E8BBD-6149-4908-964F-6395DF6BAE9AQ38753500-44672386-BA39-4896-9D75-35416CFF40CDQ38860371-46AFC515-F798-4992-87DD-636D6CCE12EBQ51292505-1644CE8E-E0A0-4E20-AD71-356E60742CF7
P2860
Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥ 65 years) with type 2 diabetes
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@ast
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@en
Long-term safety and tolerability of saxagliptin add-on therapy in older patients
@nl
type
label
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@ast
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@en
Long-term safety and tolerability of saxagliptin add-on therapy in older patients
@nl
prefLabel
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@ast
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@en
Long-term safety and tolerability of saxagliptin add-on therapy in older patients
@nl
P2093
P2860
P356
P1476
Long-term safety and tolerabil ...... 65 years) with type 2 diabetes
@en
P2093
Elsie Allen
Nayyar Iqbal
Peter Öhman
P2860
P304
P356
10.2147/CIA.S68193
P407
P577
2014-09-04T00:00:00Z